Author: Jon Hu

This author has written 3 articles
Read more about the article Breast Cancer By A New Name: Redefining Disease For Better Patient Outcomes
Blog

Breast Cancer By A New Name: Redefining Disease For Better Patient Outcomes

Everyone knows someone with cancer, so this question may be confusing, but: Does anyone have cancer anymore? What I mean is: At first, there was cancer. Now, there is chronic myeloid leukemia and acute lymphocytic leukemia; primary colorectal lymphomas and gastrointestinal stromal tumors; and six subgroups of triple-negative breast cancer. We’ve outgrown the blanket term “cancer,” and it’s making a positive difference in how we treat and overcome disease. In…

Comments Off on Breast Cancer By A New Name: Redefining Disease For Better Patient Outcomes
May 4, 2023
Read more about the article Ex-Phio VP, Simon Fricker, Joins Pepper Bio As Chief Development Officer
News

Ex-Phio VP, Simon Fricker, Joins Pepper Bio As Chief Development Officer

By Jon Hu, CEO and Cofounder of Pepper Bio  Pepper Bio, the world’s first transomics drug discovery company, announced the addition of Simon Fricker, Ph.D., as chief development officer. Previously, Dr. Fricker served three years as vice president of research and development at Phio Pharmaceuticals, a publicly-traded clinical-stage biotechnology company, and eight years as a distinguished scientific fellow at Genzyme/Sanofi. In his new role at Pepper, Dr. Fricker will support the…

Comments Off on Ex-Phio VP, Simon Fricker, Joins Pepper Bio As Chief Development Officer
December 14, 2022
Read more about the article Pepper Bio Emerges from Stealth with ‘Waze for Drug Discovery’ Technology
Pepper Bio's partnership with Stanford's Dean Felsher will target Myc addicted cancers.
Press Release

Pepper Bio Emerges from Stealth with ‘Waze for Drug Discovery’ Technology

Harvard, MIT, Cambridge, Brown & Northwestern Universities trained team leverages proprietary transomics translation technology to open a new era of drug discovery, rediscovery, and rescue. Pepper Bio, the world’s first transomics drug discovery company, emerges from stealth today to leverage its proprietary transomics -- including phosphoproteomics -- data translation technology to discover new drugs, rediscover new uses for existing therapeutics, and rescue drugs that may be on a course toward…

Comments Off on Pepper Bio Emerges from Stealth with ‘Waze for Drug Discovery’ Technology
October 15, 2021